Attana has submitted a new patent application
Attana has filed a new patent application with claims for methods for assessing the neutralising potential of antibodies in biological samples. The invention is applicable in both of Attana´s business areas – Life Science and Diagnostics.
Attana has filed a new patent application with several claims assessing the neutralising potential of antibodies or other biological entities in complex biological samples. The invention can be applied within diagnostics with the purpose to better determine the immunity of individuals based on several parameters, such as kinetics and titres of immune responding agents. Additionally, it can also be applied in both pre-clinical and clinical drug development to obtain increased information on human immune response.
The Attana patent application covers several aspects on assessing kinetics of an interaction between e.g., an antigen and an antibody as well as the combination with neutralizing titre. The work has been performed in collaboration with Prof. Ian Nicholls and Dr. Per Nilsson at the Linnaeus University. Selected parts of the invention will be published in one or more scientific publications, which will be submitted in the near future.
For more information, please contact:
Teodor Aastrup, CEO Attana AB
e-mail: teodor.aastrup@attana.com
tel: + 46 8 674 57 00
This is information that Attana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at the time stated by the Company’s news distributor, Cision, at the publication of this press release.
About Attana
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com